| | Respiratory Medicine n=183 (20%) | Palliative Medicine n=263 (22%) |
| Male | 116 (63%) | 71 (27%) |
| Years in specialty practice (median) | 13 | 12 |
| Australia | 156 (85%) | 98 (37%) |
| New Zealand | 27 (15%) | 31 (12%) |
| UK | 0 | 134 (51%) |
| Uses dyspnoea score routinely | 59 (32%) | 47 (18%) |
| Add dyspnoea medication | 127 (69%) | 239 (91%) |
Recommended treatment for refractory dyspnoea | Short acting morphine 2.5-5mg 4-6hrly PRN | 74 (58%) | 197 (82%) |
| Long acting morphine 10-20mg/24hrs | 20 (16%) | 15 (6%) |
| Low dose benzodiazepine* | 15 (12%) | 6 (3%) |